Comparison of discriminatory power and accuracy of three lung cancer risk models

British Journal of Cancer

Volumn 103, Issue 3, 2010, Pages 423-429

  D'Amelio Jr , A M ^a   Cassidy, A ^a,b   Asomaning, K ^c   Raji, O Y ^b   Duffy, S W ^d   Field, J K ^b   Spitz, M R ^a   Christiani, D ^c   Etzel, C J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

5 year lung cancer risk; discriminatory power; lung cancer; relative risks; risk model

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; GENERAL HOSPITAL; HUMAN; LIFESTYLE; LUNG CANCER; MAJOR CLINICAL STUDY; MEDICAL SCHOOL; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

CASE-CONTROL STUDIES; DISCRIMINATION (PSYCHOLOGY); HUMANS; LIFE STYLE; LUNG NEOPLASMS; MASSACHUSETTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SMOKING; SMOKING CESSATION;

EID: 77955058604     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6605759     Document Type: Article

References (34)

1. Asomaning K, Miller DP, Liu G, Wain JC, Lynch TJ, Su L, Christiani DC (2008) Second hand smoke, age of exposure and lung cancer risk. Lung Cancer 61: 13-20
2. Bach PB, Kattan MW, Thornquist MD, Kris MG, Tate RC, Barnett MJ, Hsieh LJ, Begg CB (2003) Variations in lung cancer risk among smokers. J Natl Cancer Inst 95: 470-478
3. Cassidy A, Duffy SW, Myles JP, Liloglou T, Field JK (2007) Lung cancer risk prediction: a tool for early detection. Int J Cancer 120: 1-6
4. Cassidy A, Myles JP, van Tongeren M, Page RD, Liloglou T, Duffy SW, Field JK (2008) The LLP risk model: an individual risk prediction model for lung cancer. Br J Cancer 98: 270-276
5. Cho E, Rosner BA, Feskanich D, Colditz GA (2005) Risk factors and individual probabilities of melanoma for Whites. J Clin Oncol 23: 2669-2675
6. Danaei G, Vander Hoorn S, Lopez AD, Murray CJL, Ezzati M (2005) Causes of cancer in the world: comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366: 1784-1793
7. Duffy SW, Raji OY, Agbaje OF, Allgood PC, Cassidy A, Field JK (2009) Use of lung cancer risk models in planning research and service programmes in CT screening for lung cancer. Expert Rev Anticancer Ther 9: 1467-1472
8. Fears TR, Guerry IV D, Pfeiffer RM, Sagebiel RW, Elder DE, Halpern A, Holly EA, Hartge P, Tucker MA (2006) Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol 24: 3590-3596
9. Gail MH, Brinton LA, Byar DP, Corle DK, Green SB, Schairer C, Mulvihill JJ (1989) Projecting individualized probabilities of developing breast cancer for White females who are being examined annually. J Natl Cancer Inst 81: 1879-1886
10. Garcia-Closas M, Kelsey KT, Wiencke JK, Xu X, Wain JC, Christiani DC (1997) A case-control study of cytochrome P450 1A1, glutathione S-transferase M1, cigarette smoking and lung cancer susceptibility. Cancer Causes Control 8: 544-553
11. Greenland S, Lash TL (2008) Bias analysis. In Modern Epidemiology, Rothman KJ, Greenland S, Lash TL (eds) 3rd edn, pp 345-380.
12. Lippincott-Williams-Wilkins: Philadelphia Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843
13. Hartge P, Whittemore AS, Itnyre J, McGowan L, Cramer D (1994) Rates and risks of ovarian cancer in subgroups of White women in the United States. Obstet Gynecol 84: 760-764
14. Imperiale T, Wagner D, Lin CY, Larkin GN, Rogge JD, Ransohoff DF (2000) Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal cancer findings. N Engl J Med 343: 169-174
15. Jakobsdottir J, Gorin MB, Conley YP, Ferrell RE, Weeks DE (2009) Interpretation of genetic association studies: markers with replicated highly significant odds ratios may be poor classifiers. PLoS Genet 5: 1-8. doi:10.1371/journal.pgen.1000337
16. Janssens AC, Aulchenko YS, Elefante S, Borsboom GJ, Steyerberg EW, van Duijn CM (2006) Predictive testing for complex diseases using multiple genes: fact or fiction? Genet Med 8: 395-400
17. Janssens AC, Moonesinghe R, Yang Q, Steyerberg EW, van Duijn CM, Khoury MJ (2007) The impact of genotype frequencies on the clinical validity of genomic profiling for predicting common chronic diseases. Genet Med 9: 528-535
18. Kraft P, Hunter DJ (2009) Genetic risk prediction-are we there yet? N Engl J Med 360: 1701-1703
19. Marshall RJ (2001) Displaying categorical data relationships by scaled rectangle diagrams. Stat Med 20: 1077-1088
20. Marshall RJ (2005) Scaled rectangle diagrams can be used to visualize clinical and epidemiological data. J Clin Epidemiol 58: 974-981
21. Marshall RJ (2009) Cardiovascular risk can be represented by scaled rectangle diagrams. J Clin Epidemiol 62: 998-1000
22. Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC (2003) Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms. Epidemiology 14: 545-551 (Pubitemid 40417035)
23. National Center for Health Statistics (2003) Worktable 210R. Death rates for 113 selected causes, alcohol-induced causes, drug-induced causes and injury by firearms, by 5-year age groups, race, and sex. http://www.cdc.gov/nchs/ datawh/statab/unpubd/mortabs/gmwk210-10.htm. (Last accessed July 2006)
24. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
25. Rockhill B, Byrne C, Rosner B, Louie MM, Colditz G (2003) Breast cancer risk prediction with a log-incidence model: evaluation of accuracy. J Clin Epidemiol 56: 856-861
26. Selvachandran SN, Hodder RJ, Ballal MS, Jones P, Cade D (2002) Prediction of colorectal cancer by a patient consultation questionnaire and scoring system: a prospective study. Lancet 360: 278-283
27. Spitz MR, Hong WK, Amos CI, Wu X, Schabath MB, Qiong D, Shete S, Etzel CJ (2007) A risk model for prediction of lung cancer. J Natl Cancer Inst 99: 715-726
28. Surveillance and End Results (SEER) (2005) Lung Cancer Incidence for Surveillance and End Results (SEER)-2005. US National Institutes for Health. http://www.seer.cancer.gov. (Last accessed July 2006)
29. Tice JA, Cummings SR, Ziv E, Kerlikowske K (2005) Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. Breast Cancer Res Treat 94: 115-122
30. Tyrer J, Duffy SW, Cuzick J (2004) A breast cancer prediction model incorporating familial and personal risk factors. Stat Med 23: 1111-1130
31. Vickers AJ, Kramer BS, Baker SG (2006) Selecting patients for randomized trials: a systematic approach. Trials 7: 30.
32. Wang LI, Miller DP, Sai Y, Liu G, Su L, Wain JC, Lynch TJ, Christiani DC (2001) Manganese superoxide dismutase alanine-to-valine polymorphism at codon 16 and lung cancer risk. J Natl Cancer Inst 93: 1818-1821
33. Wu X, Lin J, Grossman HB, Huang M, Gu J, Etzel CJ, Amos CI, Dinney CP, Spitz MR (2007) Projecting individualized probabilities of developing bladder cancer in White individuals. J Clin Oncol 25: 4974-4981
34. Xu X, Kelsey KT, Wiencke JK, Wain JC, Christiani DC (1996) Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiol Biomarkers Prev 5: 687-692